Side-by-side comparison of AI visibility scores, market position, and capabilities
Cambridge MA edge cloud (NASDAQ: AKAM) at $3.99B 2024 revenue with security $2B+ first to surpass CDN; 365K+ servers in 135+ countries Q2 2025 cloud infra growing 30% competing with Cloudflare for enterprise web security and edge cloud.
Akamai Technologies is a Cambridge, Massachusetts-based edge cloud company — publicly traded on NASDAQ (NASDAQ: AKAM) as an S&P 500 company — providing enterprises with content delivery (CDN), cybersecurity, and cloud computing services through the world's most distributed edge platform: 365,000+ servers across 4,200+ points of presence in 135+ countries. In 2024, Akamai reported $3.99 billion in revenue (5% year-over-year growth) with security products generating $2+ billion (16% growth) — the first year in the company's 27-year history that security represented the largest revenue segment. In Q2 2025, Akamai reported $1.043 billion in revenue (7% growth) with cloud infrastructure growing 30% year-over-year. The business model transformation from CDN-dominant to security-dominant to cloud-expanding reflects CEO and co-founder Dr. Tom Leighton's strategy to leverage the distributed edge network for adjacent high-growth services. Founded in 1998 by MIT professors Tom Leighton and Danny Lewin.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.